Medico-economic Evaluation of a Project of Wounds by a Remote Network (DOMOPLAIES)

April 11, 2016 updated by: University Hospital, Montpellier

Medico-economic Evaluation of the DOMOPLAIES Project by the CICAT-LR Network

Estimate in 6 months the impact of the telemedicine on the cure rate of the chronic wounds compared with the usual care(with or without CICAT-LR Network).

Study Overview

Study Type

Interventional

Enrollment (Actual)

193

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • Wound healing Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Being adult
  • Taken up residence on the Languedoc-Roussillon
  • Patient carrying a wound with healing or improvement objective (wound closure or the appearance of 40% of granulation)
  • Informed consent signed,
  • Patient member of the Security Social
  • Patient having a visiting nurse.

Exclusion Criteria:

  • Patient in vital or functional emergency situation during the first call or during the consultation
  • Tumoral wound
  • dialysis patient
  • Arteritis of stage 4 and not revascularizable
  • Absence of regular doctor and visiting nurse
  • patient refusal
  • Refusal of one of the health professionals participating in the pathology care
  • Anybody incapable to communicate and to answer the questions
  • Pregnant or nursing woman
  • Subject deprived of freedom by court or administrative order
  • Major subject protected by the law
  • For the patients in telemedicine: refusal of the collaboration agreement

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Telemedicine

In the telemedicine arm, all patients will be supported by Telemedicine protocol according to the development of telemedicine in the region.

The use of teleconsultation allows the couple expert doctor / nurse expert to perform a complex of wound assessment consultation and / or chronic. The use of telemedicine allows for acts of telecare, when the nurse applicant sought a remote support of an expert nurse (under the responsibility of a doctor) for the realization of an act. The use of tele-expertise enables physicians to remotely bring special expertise to improve patient care.

Active Comparator: Control

In the control arm, patient care depend on his home, as is currently the case:

  • If it is in the action zone of Cicat-LR network, then it will be supported by an expert nurse of the network that are physically visit the patient's home-lon is the protocols established by the network.
  • If not, then it will be supported by the customs of the attending physician and nursing teams who follow him.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of healed chronic wounds during a telemedicine care
Time Frame: Six months after inclusion
Rate of healed chronic wounds during a telemedicine care versus during a usual medical care
Six months after inclusion
Rate of healed chronic wounds during a usual medical care
Time Frame: Six months after inclusion
Rate of healed chronic wounds during a telemedicine care versus during a usual medical care
Six months after inclusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Result to the questionnaire on the quality of life: EQ-5D
Time Frame: Six months after inclusion
Compare the quality of life of patients with chronic wounds during a telemedicine coverage versus during a usual medical care, thanks to the EQ-5D quality life scale.
Six months after inclusion
A measure of the costs of the management of the disease
Time Frame: Seven months after the inclusion of the last patient
A measure of the costs of the management of the disease (consumer care, hospitalization, transport ...)
Seven months after the inclusion of the last patient
A measure of the costs of the intervention assessed
Time Frame: Seven months after the inclusion of the last patient
A measure of the costs of the intervention assessed (investment, maintenance, training ...).
Seven months after the inclusion of the last patient
The total healing time
Time Frame: Six months after inclusion
Six months after inclusion
The decrease in centimeters of the wound surface to 6 months
Time Frame: Six months after inclusion
Six months after inclusion
The response time between making an appointment and support
Time Frame: Six months after inclusion
Six months after inclusion
The mortality rate within 6 months
Time Frame: Six months after inclusion
Six months after inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Actual)

October 1, 2015

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

September 2, 2015

First Submitted That Met QC Criteria

September 9, 2015

First Posted (Estimate)

September 10, 2015

Study Record Updates

Last Update Posted (Estimate)

April 12, 2016

Last Update Submitted That Met QC Criteria

April 11, 2016

Last Verified

April 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 9250

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Resident of Languedoc-roussillon

Clinical Trials on Control

Subscribe